Implantica AG (IPLTF)
OTCMKTS · Delayed Price · Currency is USD
6.24
0.00 (0.00%)
Sep 15, 2026, 9:30 AM EST

Implantica AG Statistics

Total Valuation

Implantica AG has a market cap or net worth of 1.69 billion. The enterprise value is 1.64 billion.

Market Cap1.69B
Enterprise Value 1.64B

Important Dates

The next confirmed earnings date is Thursday, November 19, 2026.

Earnings Date Nov 19, 2026
Ex-Dividend Date n/a

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) +0.06%
Shares Change (QoQ) +0.01%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 7.64M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 597.66
PB Ratio 19.61
P/TBV Ratio 32.42
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 14.69, with a Debt / Equity ratio of 0.00.

Current Ratio 14.69
Quick Ratio 14.57
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF -0.01
Interest Coverage -41.68

Financial Efficiency

Return on equity (ROE) is -23.65% and return on invested capital (ROIC) is -14.77%.

Return on Equity (ROE) -23.65%
Return on Assets (ROA) -14.30%
Return on Invested Capital (ROIC) -14.77%
Return on Capital Employed (ROCE) -26.30%
Weighted Average Cost of Capital (WACC) 8.58%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count46
Asset Turnover 0.03
Inventory Turnover 9.54

Taxes

In the past 12 months, Implantica AG has paid 33,131 in taxes.

Income Tax 33,131
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) 0.78
52-Week Price Change n/a
50-Day Moving Average n/a
200-Day Moving Average n/a
Relative Strength Index (RSI) n/a
Average Volume (20 Days) 724

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Implantica AG had revenue of 2.82 million and -22.53 million in losses. Loss per share was -0.08.

Revenue2.82M
Gross Profit -210,214
Operating Income -22.72M
Pretax Income -22.67M
Net Income -22.53M
EBITDA -22.73M
EBIT -22.72M
Loss Per Share -0.08
Full Income Statement

Balance Sheet

The company has 47.68 million in cash and 217,068 in debt, with a net cash position of 47.46 million.

Cash & Cash Equivalents 47.68M
Total Debt 217,068
Net Cash 47.46M
Net Cash Per Share n/a
Equity (Book Value) 85.98M
Book Value Per Share 0.31
Working Capital 48.20M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -17.92 million and capital expenditures -5,712, giving a free cash flow of -17.93 million.

Operating Cash Flow -17.92M
Capital Expenditures -5,712
Depreciation & Amortization -14,809
Net Borrowing -94,550
Free Cash Flow -17.93M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin -7.45%
Operating Margin -805.31%
Pretax Margin -803.60%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Implantica AG does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -0.06%
Shareholder Yield -0.06%
Earnings Yield -1.34%
FCF Yield -1.06%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Implantica AG has an Altman Z-Score of 242.82 and a Piotroski F-Score of 3.

Altman Z-Score 242.82
Piotroski F-Score 3